Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia

✍ Scribed by Francisco Javier Peñalver; Alberto Alvarez-Larrán; Jose Luis Díez-Martin; Laura Gallur; Isidro Jarque; Dolores Caballero; Joaquín Díaz-Mediavilla; Rosalía Bustelos; María Jesús Fernández-Aceñero; José Rafael Cabrera; on behalf of the Multi-institutional Retrospective Study on the use of rituximab in refractory AIHA

• Publisher: Springer
• Year: 2010
• Tongue: English
• Weight: 229 KB
• Volume: 89
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/s00277-010-0997-y